Skip to main content

Table 3 Distribution of clinical and laboratory characteristics across the three clusters. Continuous variables are presented as mean (sd); categorical variables are presented as counts and percentages (%)

From: Cluster analysis of angiotensin biomarkers to identify antihypertensive drug treatment in population studies

Variable

Cluster 1 (n = 444)

Cluster 2 (n = 235)

Cluster 3 (n = 121)

P-value*

Age (Year)

66.57(9.1)

65.71(9.7)

68.6(10.5)

0.1826

Sex F: n(%)

240(54.0)

129(55.0)

63(52.0)

0.8789

BMI (kg/m2)

27.4(4.5)

29.0(4.9)

29.3(4.5)

0.0021

HbA1c (%)

5.91(0.47)

6.04(0.63)

6.04(0.52)

1.05 × 10− 6

Glucose (mg/dl)

98.76(15)

104.38(23.12)

102.48(15.69)

4.42 × 10− 5

Total cholesterol (mg/dl)

224.19(41.68)

220.01(44.99)

221.36(41.83)

0.3235

eGFR (ml/min/1.73m2)

78.34(12.47)

74.51(14.85)

73.55(15.77)

0.0070

Sodium (mmol/L)

141.1(2.19)

140.73(2.49)

140.53(2.23)

0.8505

Potassium (mmol/L)

4.59(0.38)

4.58(0.41)

4.59(0.42)

0.7828

Cortisol (µg/dl)

13.53(4.52)

13.69(4.73)

13.59(4.89)

0.0967

SBP (mmHg)

137.99(18.46)

132.4(14.63)

137.54(17.9)

0.0434

DBP (mmHg)

85.27(9.4)

83.56(8.5)

83.96(9.42)

0.0019

Diabetes: n(%)

42(9%)

51(22%)

25(21%)

1.45 × 10− 5

  1. *From one-way ANOVA for continuous and Chi-square test for categorical variables